Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder CancerRussell E.N. Becker, Trinity J. Bivalacqua, Alex S. Baras et al.|European Urology|2020Cited by 72
Hospital Charges and Length of Stay Following Radical Cystectomy in the Enhanced Recovery After Surgery EraAlice Semerjian, Trinity J. Bivalacqua, Niv Milbar et al.|Urology|2017Cited by 64
Comparison of Pathological Stage in Patients Treated with and without Neoadjuvant Chemotherapy for High Risk Upper Tract Urothelial CarcinomaRoss Liao, Phillip M. Pierorazio, Mohit Gupta et al.|The Journal of Urology|2018Cited by 61
Causes, Timing, Hospital Costs and Perioperative Outcomes of Index vs Nonindex Hospital Readmissions after Radical Cystectomy: Implications for Regionalization of CareMeera R. Chappidi, Trinity J. Bivalacqua, Max Kates et al.|The Journal of Urology|2016Cited by 52
Circulating Tumor Cell and Circulating Tumor DNA Assays Reveal Complementary Information for Patients with Metastatic Urothelial CancerHeather J. Chalfin, David J. McConkey, Stephanie Glavaris et al.|European Urology Oncology|2019Cited by 43